Nuvation Bio Inc.
NUVB
$4.32
-$0.40-8.48%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.40M | -36.59M | -55.79M | -59.01M | -53.24M |
| Total Depreciation and Amortization | 536.00K | 539.00K | 534.00K | 356.00K | 310.00K |
| Total Amortization of Deferred Charges | 321.00K | 327.00K | 317.00K | 18.00K | -- |
| Total Other Non-Cash Items | 10.31M | 12.27M | 10.71M | 10.26M | 7.54M |
| Change in Net Operating Assets | -11.50M | -6.28M | -8.66M | 194.00K | 2.76M |
| Cash from Operations | 5.07M | -29.73M | -52.89M | -48.18M | -42.63M |
| Capital Expenditure | -48.00K | -89.00K | -12.00K | -181.00K | -72.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.59M | 87.17M | -96.61M | 55.06M | 54.25M |
| Cash from Investing | -43.64M | 87.08M | -96.62M | 54.88M | 54.18M |
| Total Debt Issued | -- | 11.20M | 0.00 | 198.90M | -- |
| Total Debt Repaid | -864.00K | -11.62M | -68.00K | -166.00K | -534.00K |
| Issuance of Common Stock | 908.00K | 8.49M | 558.00K | 1.30M | 1.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 11.00K | -6.61M | -- |
| Cash from Financing | 44.00K | 8.06M | 501.00K | 193.42M | 548.00K |
| Foreign Exchange rate Adjustments | -172.00K | -224.00K | -64.00K | -128.00K | 151.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.70M | 65.19M | -149.07M | 199.99M | 12.25M |